Phase 2 Trial of a Haemophilus Influenzae Serotype a (Hia) Glycoconjugate Vaccine
Clinical trial NCT07743008 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07743008
- Sponsor
- InventVacc Biologicals Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-29
- Primary completion
- 2027-02-03
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.